News Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Continue Reading Previous Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical UpdateNext Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™ Related Stories News SPARC AI Receives Order for Mobile GPS-Denied Navigation Solution from UAE Group Supporting Defence Operations News ResVR Unveils Full Product Suite, Redefining the Virtual Homebuying Experience News Circle Cardiovascular Imaging Expands cvi42 Platform with Advanced Vascular CT Capabilities News QCI and IWP Complete Live Entertainment Streaming Pilot at Pala Casino News Verum Messenger Introduces macOS Application Version News Zermit AI Launches AI Platform That Lets Contractors and Homeowners Submit Building Permits Through Chat
